Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.99 is 94% above its 5-year average of -16.84, near the high end of its 5-year range (-84.60–-0.99).
71.75% above its 12-month average of -3.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.99
EARNINGS PER SHARE (EPS) AVG TTM
-3.50
EARNINGS PER SHARE (EPS) AVG 3Y
-23.24
EARNINGS PER SHARE (EPS) AVG 5Y
-16.84
EARNINGS PER SHARE (EPS) AVG 10Y
-10.05
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+71.75%
CURRENT VS 3Y AVG
+95.74%
CURRENT VS 5Y AVG
+94.12%
CURRENT VS 10Y AVG
+90.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Teladoc Health, Inc.
Market Cap
$1.15B
Earnings Per Share (EPS)
-0.99
TTM Avg
-3.50
3Y Avg
-23.24
5Y Avg
-16.84
Market Cap
$365.20M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$1.99B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$50.89M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$3.04B
Earnings Per Share (EPS)
3.86
TTM Avg
3.33
3Y Avg
1.17
5Y Avg
0.32
Market Cap
$4.96B
Earnings Per Share (EPS)
0.85
TTM Avg
1.12
3Y Avg
0.90
5Y Avg
0.76
Market Cap
$5.21B
Earnings Per Share (EPS)
2.42
TTM Avg
2.12
3Y Avg
1.80
5Y Avg
1.31
Market Cap
$6.13B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.15B | -0.99 | -3.50 | -23.24 | -16.84 |
| NRC Health (NRC)vs › | $492.65M | 0.25 | 0.79 | 1.03 | 1.18 |
| Shoulder Innovations, Inc. (SI)vs › | $365.20M | -1.71 | -1.36 | -1.12 | -1.12 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.99B | -2.74 | -3.74 | -3.13 | -1.84 |
| PDS Biotechnology Corporation (PDSB)vs › | $50.89M | -0.64 | -0.89 | -1.15 | -1.02 |
| TransMedics Group, Inc. (TMDX)vs › | $3.04B | 3.86 | 3.33 | 1.17 | 0.32 |
| Doximity, Inc. (DOCS)vs › | $4.96B | 0.85 | 1.12 | 0.90 | 0.76 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.21B | 2.42 | 2.12 | 1.80 | 1.31 |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.13B | -3.31 | -2.88 | -2.49 | -2.72 |
| Chemed Corporation (CHE)vs › | $6.49B | 19.92 | 19.26 | 18.34 | 18.42 |
Trailing EPS (TTM)
$-0.99
Forward EPS (Est.)
$-0.86
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.14 |
| 2024-12-31 | -5.87 |
| 2023-12-31 | -1.36 |
| 2022-12-31 | -84.60 |
| 2021-12-31 | -2.73 |
| 2020-12-31 | -5.36 |
| 2019-12-31 | -1.38 |
| 2018-12-31 | -1.47 |
| 2017-12-31 | -1.93 |
| 2016-12-31 | -1.75 |
| 2015-12-31 | -2.91 |
| 2014-12-31 | -0.62 |
| 2013-12-31 | -0.22 |
